John Furey

Filings by John Furey span 2 companies, the busiest being Spark Therapeutics, Inc. and Vaxcyte, Inc. Between 8 December 2017 and 15 June 2026, the trades on record add up to 12 filings.

Market trades split into 1 purchase (€1,124) and 5 sales (€2.6M). Taken together, the sales exceed the purchases by €2.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants and 4 option exercises.

On 16 June 2026 came the latest disclosure, a share grant in Vaxcyte, Inc. The latest purchase dates back some time: it was published 3,213 days ago, on 22 January 2018. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.